OMRI Omrix Biopharmaceuticals (MM)

Law Offices of Brian M. Felgoise, P.C. announces that a class action has been commenced on behalf of shareholders of Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI) in connection with the offer by Johnson & Johnson to acquire all of the outstanding shares of OMRI.

The case is pending in The Supreme Court of the State of New York, County of New York against certain officers and directors. The goal of the lawsuit is to seek the highest possible offer for the public shares.

If you are a holder of Omrix Biopharmaceuticals, Inc. stock and want to discuss your legal rights, you may e-mail or call Law Offices of Brian M. Felgoise, P.C. who will, without obligation or cost to you, attempt to answer your questions. Law Offices of Brian M. Felgoise, P.C. has extensive experience in the field of class actions. You may contact Brian M. Felgoise, Esquire at 261 Old York Road, Suite 423, Jenkintown, Pennsylvania 19046, by calling (215) 886-1900 or by e-mail at FelgoiseLaw@verizon.net.

Please Contact: Law Offices of Brian M. Felgoise, P.C. 261 Old York Road, Suite 423 Jenkintown, PA 19046 Email Contact